COVID-19 and the Use of Immunomodulatory Agents in Ophthalmology
Immunomodulatory agents are often used in the systemic treatment of non-infectious uveitis. These drugs consist of corticosteroids, conventional immunosuppressives, and biological agents. As it is known that they suppress the immune system, the most important concern associated with immunomodulatory...
Main Authors: | Mehmet Fatih Kağan Değirmenci, F. Nilüfer Yalçındağ, İlknur Tugal-Tutkun |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2021-08-01
|
Series: | Türk Oftalmoloji Dergisi |
Subjects: | |
Online Access: |
http://www.oftalmoloji.org/archives/archive-detail/article-preview/covd-19-and-the-use-of-mmunomodulatory-agents-in-o/48750
|
Similar Items
-
Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
by: F. Nilüfer Yalçındağ, et al.
Published: (2021-08-01) -
Immunological tests and their interpretation in uveitis
by: S R Rathinam, et al.
Published: (2020-01-01) -
Pars planitis: Epidemiology, clinical characteristics, management and visual prognosis
by: Pinar Cakar Ozdal, et al.
Published: (2015-01-01) -
Methotrexate Effectively Controls Ocular Inflammation in Japanese Patients With Non-infectious Uveitis
by: Yosuke Harada, et al.
Published: (2021-11-01) -
High-Dimensional Profiling Reveals Heterogeneity of the Th17 Subset and Its Association With Systemic Immunomodulatory Treatment in Non-infectious Uveitis
by: Fleurieke H. Verhagen, et al.
Published: (2018-10-01)